Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Bacterial Infections and Mycoses

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 121 articles:
HTML format
Text format



Single Articles


    July 2019
  1. BASHAM CA, Elias B, Orr P
    Tuberculosis elimination in Canada.
    Lancet. 2019;394:300-301.
    PubMed     Text format    


  2. MENZIES D, Benedetti A, Migliori GB, Nahid P, et al
    Multidrug-resistant tuberculosis - Authors' reply.
    Lancet. 2019;394:299-300.
    PubMed     Text format    


  3. CHIANG CY, Van Deun A, Trebucq A, Piubello A, et al
    Multidrug-resistant tuberculosis.
    Lancet. 2019;394:299.
    PubMed     Text format    


  4. CAMINERO JA, Garcia-Basteiro AL, Rendon A
    Multidrug-resistant tuberculosis.
    Lancet. 2019;394:298.
    PubMed     Text format    


  5. NYANG'WA BT, Berry C, Fielding K, Nunn AJ, et al
    Multidrug-resistant tuberculosis.
    Lancet. 2019;394:298-299.
    PubMed     Text format    


  6. CARLSON CJ, Mendenhall E
    Preparing for emerging infections means expecting new syndemics.
    Lancet. 2019;394:297.
    PubMed     Text format    


  7. LAVOIE PM, Popescu CR, Molyneux EM, Wynn JL, et al
    Rethinking management of neonates at risk of sepsis.
    Lancet. 2019;394:279-281.
    PubMed     Text format    


  8. WANG HH, Lau E, Horton R, Jiang B, et al
    The Wakley-Wu Lien Teh Prize Essay 2019: telling the stories of Chinese doctors.
    Lancet. 2019;394:11.
    PubMed     Text format    


    June 2019
  9. KNIGHT M, Chiocchia V, Partlett C, Rivero-Arias O, et al
    Prophylactic antibiotics in the prevention of infection after operative vaginal delivery (ANODE): a multicentre randomised controlled trial.
    Lancet. 2019;393:2395-2403.
    PubMed     Text format     Abstract available


  10. MORI Y, Katasako A, Matsunaga S, Matono T, et al
    Tetanus: remember to vaccinate.
    Lancet. 2019;393:2331.
    PubMed     Text format    


    May 2019
  11. RYAN JM, Feder HM Jr
    Dog licks baby. Baby gets Pasteurella multocida meningitis.
    Lancet. 2019;393:e41.
    PubMed     Text format    


  12. USHER AD
    Low-cost pneumonia vaccine breaks into global market.
    Lancet. 2019;393:2025-2026.
    PubMed     Text format    


  13. FRIEBEL R, Silverman R, Glassman A, Chalkidou K, et al
    On results reporting and evidentiary standards: spotlight on the Global Fund.
    Lancet. 2019;393:2006-2008.
    PubMed     Text format    


  14. KIRKCALDY RD, Workowski KA
    Gentamicin as an alternative treatment for gonorrhoea.
    Lancet. 2019 May 2. pii: S0140-6736(19)30244.
    PubMed     Text format    


  15. ROSS JDC, Brittain C, Cole M, Dewsnap C, et al
    Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.
    Lancet. 2019 May 2. pii: S0140-6736(18)32817.
    PubMed     Text format     Abstract available


    April 2019
  16. ZHONG D, Yi Y, Lin C
    A kidney changes size: first increasing and then decreasing.
    Lancet. 2019;393:1641.
    PubMed     Text format    


  17. YEN LM, Thwaites CL
    Tetanus.
    Lancet. 2019;393:1657-1668.
    PubMed     Text format     Abstract available


  18. KLUGMAN KP, Rodgers GL
    Population versus individual protection by pneumococcal conjugate vaccination.
    Lancet. 2019 Apr 15. pii: S0140-6736(19)30039.
    PubMed     Text format    


  19. HAMMITT LL, Etyang AO, Morpeth SC, Ojal J, et al
    Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study.
    Lancet. 2019 Apr 15. pii: S0140-6736(18)33005.
    PubMed     Text format     Abstract available


  20. PAN D, Arkell P, Stone NRH, Parkinson B, et al
    Delayed Strongyloides stercoralis hyperinfection syndrome in a renal transplant patient with Pneumocystis jirovecii pneumonia receiving high-dose corticosteroids.
    Lancet. 2019;393:1536.
    PubMed     Text format    


  21. HONIGSBAUM M
    Disease X and other unknowns.
    Lancet. 2019;393:1496-1497.
    PubMed     Text format    


    March 2019
  22. ABUBAKAR I, Plasencia A, Barnighausen T, Froeschl G, et al
    Horizon Europe: towards a European agenda for global health research and innovation.
    Lancet. 2019;393:1272-1273.
    PubMed     Text format    


  23. MIMOZ O, Guenezan J
    No benefit of chlorhexidine bathing in non-critical care units.
    Lancet. 2019;393:1179-1180.
    PubMed     Text format    


  24. HUANG SS, Septimus E, Kleinman K, Moody J, et al
    Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial.
    Lancet. 2019;393:1205-1215.
    PubMed     Text format     Abstract available


  25. ZUCCALA E, Horton R
    Time to bring tuberculosis out of the shadows.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30486.
    PubMed     Text format    


  26. KI-MOON B
    Building a tuberculosis-free world on a foundation of universal health coverage.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30433.
    PubMed     Text format    


  27. ZAROCOSTAS J
    Nandita Venkatesan: a voice of hope for tuberculosis survivors.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30582.
    PubMed     Text format    


  28. NADDA JP
    India's leadership to end tuberculosis.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30487.
    PubMed     Text format    


  29. KUMAR A
    Picturing health: it's time to act on tuberculosis.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30583.
    PubMed     Text format    


  30. WEBSTER P
    Inuit research raises concerns about tuberculosis eradication.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30681.
    PubMed     Text format    


  31. REID MJA, Arinaminpathy N, Bloom A, Bloom BR, et al
    Building a tuberculosis-free world: The Lancet Commission on tuberculosis.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30024.
    PubMed     Text format    


  32. FURIN J, Cox H, Pai M
    Tuberculosis.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30308.
    PubMed     Text format     Abstract available


  33. WATTS G
    Christine Sekaggya-Wiltshire: prizewinner in HIV-tuberculosis research.
    Lancet. 2019 Mar 19. pii: S0140-6736(19)30644.
    PubMed     Text format    


  34. FADEL SA, Boschi-Pinto C, Yu S, Reynales-Shigematsu LM, et al
    Trends in cause-specific mortality among children aged 5-14 years from 2005 to 2016 in India, China, Brazil, and Mexico: an analysis of nationally representative mortality studies.
    Lancet. 2019;393:1119-1127.
    PubMed     Text format     Abstract available


  35. AZZOPARDI PS, Hearps SJC, Francis KL, Kennedy EC, et al
    Progress in adolescent health and wellbeing: tracking 12 headline indicators for 195 countries and territories, 1990-2016.
    Lancet. 2019;393:1101-1118.
    PubMed     Text format     Abstract available


  36. PAGE KR, Doocy S, Reyna Ganteaume F, Castro JS, et al
    Venezuela's public health crisis: a regional emergency.
    Lancet. 2019 Mar 11. pii: S0140-6736(19)30344.
    PubMed     Text format     Abstract available


  37. OLMEDO-RENEAUM A, Garcia-Juarez I, Toapanta-Yanchapaxi L, De La Pena-Lopez R, et al
    Rogue "stem cell clinic" leads to Mycobacterium abscessus infection.
    Lancet. 2019;393:918.
    PubMed     Text format    


    February 2019
  38. STORY A, Aldridge RW, Smith CM, Garber E, et al
    Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial.
    Lancet. 2019 Feb 21. pii: S0140-6736(18)32993.
    PubMed     Text format     Abstract available


  39. FRASER H, Keshavjee S
    Video-observed therapy for tuberculosis: strengthening care.
    Lancet. 2019 Feb 21. pii: S0140-6736(19)30293.
    PubMed     Text format    


  40. KUMAR A, Lambert S, Lockwood DNJ
    Picturing health: a new face for leprosy.
    Lancet. 2019;393:629-638.
    PubMed     Text format    


  41. THE LANCET
    Abandoning the stigma of leprosy.
    Lancet. 2019;393:378.
    PubMed     Text format    


  42. GOSTIN L, Phelan A, Coutinho AG, Eccleston-Turner M, et al
    Ebola in the Democratic Republic of the Congo: time to sound a global alert?
    Lancet. 2019 Feb 1. pii: S0140-6736(19)30243.
    PubMed     Text format    


    January 2019
  43. CHEKHCHAR M, Hajji I, Madiq B, Darfaoui Z, et al
    Mitral stenosis found after eye problem.
    Lancet. 2019;393:275.
    PubMed     Text format    


  44. BARNETT R
    Cholera.
    Lancet. 2019;393:218.
    PubMed     Text format    



  45. Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial.
    Lancet. 2019 Jan 8. pii: S0140-6736(18)32221.
    PubMed     Text format     Abstract available


  46. DOYLE LW, Cheong JLY
    Does bovine lactoferrin prevent late-onset neonatal sepsis?
    Lancet. 2019 Jan 8. pii: S0140-6736(18)32390.
    PubMed     Text format    


  47. FERRY G
    Dorothy Stopford Price and the control of tuberculosis in Ireland.
    Lancet. 2019;393:20.
    PubMed     Text format    


    December 2018
  48. SAVIOLI L, Daumerie D
    WHO leadership is essential for the elimination of NTDs.
    Lancet. 2018;390:2765.
    PubMed     Text format    


  49. YAQUB F
    2017: a year in review.
    Lancet. 2018;390:2753-2754.
    PubMed     Text format    


  50. THE LANCET
    Our responsibility to protect the Rohingya.
    Lancet. 2018;390:2740.
    PubMed     Text format    


  51. BLUMENTHAL KG, Peter JG, Trubiano JA, Phillips EJ, et al
    Antibiotic allergy.
    Lancet. 2018 Dec 14. pii: S0140-6736(18)32218.
    PubMed     Text format     Abstract available


  52. OLSAVSZKY V, Geraud C
    Liaison leads to solitary syphilitic chancre on the neck.
    Lancet. 2018;392:2397.
    PubMed     Text format    


  53. VAN DER HEIJDE D, Baraliakos X, Gensler LS, Maksymowych WP, et al
    Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial.
    Lancet. 2018;392:2378-2387.
    PubMed     Text format     Abstract available


  54. MEASE P, Coates LC, Helliwell PS, Stanislavchuk M, et al
    Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial.
    Lancet. 2018;392:2367-2377.
    PubMed     Text format     Abstract available


  55. MBONYE AK, Sekamatte M
    Disease outbreaks and reporting in Uganda.
    Lancet. 2018;392:2347-2348.
    PubMed     Text format    


    November 2018

  56. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    Lancet. 2018;392:1859-1922.
    PubMed     Text format     Abstract available


  57. MARMORA L, Casas CP, Grubb I, McClure C, et al
    Long-acting technologies for infectious diseases in LMICs.
    Lancet. 2018;392:1610-1611.
    PubMed     Text format    


  58. GRANICH R
    Is the global tuberculosis control strategy too big to fail?
    Lancet. 2018 Nov 1. pii: S0140-6736(18)32751.
    PubMed     Text format    


    October 2018
  59. HOCKING JS, Temple-Smith M, Guy R, Donovan B, et al
    Population effectiveness of opportunistic chlamydia testing in primary care in Australia: a cluster-randomised controlled trial.
    Lancet. 2018;392:1413-1422.
    PubMed     Text format     Abstract available


  60. ADAMSON PC, Klausner JD
    No benefit of chlamydia screening in primary care?
    Lancet. 2018;392:1381-1383.
    PubMed     Text format    


  61. MARKS F, Kim JH, Rakotozandrindrainy R
    Madagascar should introduce typhoid conjugate vaccines now.
    Lancet. 2018;392:1309-1310.
    PubMed     Text format    


  62. KLEBANOFF MA, Brotman RM
    Treatment of bacterial vaginosis to prevent preterm birth.
    Lancet. 2018 Oct 12. pii: S0140-6736(18)32115.
    PubMed     Text format    


  63. SUBTIL D, Brabant G, Tilloy E, Devos P, et al
    Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial.
    Lancet. 2018 Oct 12. pii: S0140-6736(18)31617.
    PubMed     Text format     Abstract available


  64. THE LANCET
    Congenital syphilis in the USA.
    Lancet. 2018;392:1168.
    PubMed     Text format    


  65. COUSINS S
    UN High-Level meeting to end tuberculosis disappointing.
    Lancet. 2018 Oct 3. pii: S0140-6736(18)32458.
    PubMed     Text format    


    September 2018
  66. MAKONI M
    Inside Zimbabwe's efforts to tame cholera.
    Lancet. 2018;392:e8.
    PubMed     Text format    


  67. MARAIS B, Zumla A
    Advancing global tuberculosis control after the UNGA-HLM.
    Lancet. 2018 Sep 24. pii: S0140-6736(18)32361.
    PubMed     Text format    


  68. THE LANCET
    Monkeypox contacts: a puzzling problem.
    Lancet. 2018;392:986.
    PubMed     Text format    


  69. TRIPATHI M, Mohindra S
    Rhinocerebral aspergillosis.
    Lancet. 2018;392:e8.
    PubMed     Text format    


  70. AHMAD N, Ahuja SD, Akkerman OW, Alffenaar JC, et al
    Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
    Lancet. 2018;392:821-834.
    PubMed     Text format     Abstract available


  71. FARMER PE
    Better and safer treatment for multidrug-resistant tuberculosis.
    Lancet. 2018;392:798-800.
    PubMed     Text format    


  72. REUTER A, Furin J
    Reducing harm in the treatment of multidrug-resistant tuberculosis.
    Lancet. 2018;392:797-798.
    PubMed     Text format    


    August 2018
  73. COUSINS S
    Experts fear a resurgence of leprosy in India.
    Lancet. 2018;392:624-625.
    PubMed     Text format    


  74. THWAITES GE, Szubert A, Walker AS
    Rifampicin in treating S aureus bacteraemia - Authors' reply.
    Lancet. 2018;392:555-556.
    PubMed     Text format    


  75. RIEG S, Kern WV, Soriano A
    Rifampicin in treating S aureus bacteraemia.
    Lancet. 2018;392:554-555.
    PubMed     Text format    


  76. THE LANCET
    Zika-associated health and development problems in children.
    Lancet. 2018;392:532.
    PubMed     Text format    


  77. MBOI N, Murty Surbakti I, Trihandini I, Elyazar I, et al
    On the road to universal health care in Indonesia, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Lancet. 2018;392:581-591.
    PubMed     Text format     Abstract available


  78. BURZA S, Croft SL, Boelaert M
    Leishmaniasis.
    Lancet. 2018 Aug 17. pii: S0140-6736(18)31204.
    PubMed     Text format     Abstract available


  79. GARBARINO MC, Cani V, Mazzarello P
    A century ago: Carlo Forlanini and the first successful treatment of tuberculosis.
    Lancet. 2018;392:475.
    PubMed     Text format    


  80. THE LANCET
    Introducing EU-wide surveillance of Lyme neuroborreliosis.
    Lancet. 2018;392:452.
    PubMed     Text format    


    July 2018
  81. WALLACE DJ, Furie RA, Tanaka Y, Kalunian KC, et al
    Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial.
    Lancet. 2018;392:222-231.
    PubMed     Text format     Abstract available


  82. GUPTA-WRIGHT A, Corbett EL, van Oosterhout JJ, Wilson D, et al
    Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31267.
    PubMed     Text format     Abstract available


  83. NATHAVITHARANA RR, Pai M
    New strategies for inpatients with HIV and tuberculosis.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31442.
    PubMed     Text format    


  84. SEALE AC, Agarwal R
    Improving management of neonatal infections.
    Lancet. 2018;392:100-102.
    PubMed     Text format    


  85. KARTHIKEYAN G, Guilherme L
    Acute rheumatic fever.
    Lancet. 2018;392:161-174.
    PubMed     Text format     Abstract available


  86. SAHA SK, Schrag SJ, El Arifeen S, Mullany LC, et al
    Causes and incidence of community-acquired serious infections among young children in south Asia (ANISA): an observational cohort study.
    Lancet. 2018;392:145-159.
    PubMed     Text format     Abstract available


    June 2018
  87. KRAEF C, Arand J, Veletzky L, Schafer H, et al
    Schistosomiasis detected during appendectomy.
    Lancet. 2018;391:2546.
    PubMed     Text format    


  88. CECCONI M, Evans L, Levy M, Rhodes A, et al
    Sepsis and septic shock.
    Lancet. 2018 Jun 21. pii: S0140-6736(18)30696.
    PubMed     Text format     Abstract available


  89. XIE X, Bai J
    Concentric circles in left atrium.
    Lancet. 2018;391:2448.
    PubMed     Text format    


  90. SALAMA PJ, Embarek PKB, Bagaria J, Fall IS, et al
    Learning from listeria: safer food for all.
    Lancet. 2018;391:2305-2306.
    PubMed     Text format    


  91. THE LANCET
    Active case finding for communicable diseases in prisons.
    Lancet. 2018;391:2186.
    PubMed     Text format    



  92. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016.
    Lancet. 2018;391:2236-2271.
    PubMed     Text format     Abstract available


    May 2018
  93. CHATTOPADHYAY A, Sharma A, Gupta K, Jain S, et al
    The Phemister triad.
    Lancet. 2018;391:e20.
    PubMed     Text format    


  94. THE LANCET
    Balancing treatment with resistance in UTIs.
    Lancet. 2018;391:1966.
    PubMed     Text format    


  95. QADRI F, Azad AK, Flora MS, Khan AI, et al
    Emergency deployment of oral cholera vaccine for the Rohingya in Bangladesh.
    Lancet. 2018;391:1877-1879.
    PubMed     Text format    


  96. LESSLER J, Moore SM, Luquero FJ, McKay HS, et al
    Mapping the burden of cholera in sub-Saharan Africa and implications for control: an analysis of data across geographical scales.
    Lancet. 2018;391:1908-1915.
    PubMed     Text format     Abstract available


  97. MINTZ E
    Taking aim at cholera.
    Lancet. 2018;391:1868-1870.
    PubMed     Text format    


  98. COUSINS S
    Managing MDR tuberculosis in Nepal.
    Lancet. 2018;391:1760-1761.
    PubMed     Text format    


  99. GUENOT M
    Roger Glass: celebrating the Fogarty at 50.
    Lancet. 2018;391:1765.
    PubMed     Text format    


    April 2018
  100. CHU DK, Kim LH, Young PJ, Zamiri N, et al
    Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis.
    Lancet. 2018;391:1693-1705.
    PubMed     Text format     Abstract available


  101. COSTELLO A
    The Global Fund links with Lombard Odier bank.
    Lancet. 2018;391:1674-1675.
    PubMed     Text format    


  102. MITJA O, Godornes C, Houinei W, Kapa A, et al
    Re-emergence of yaws after single mass azithromycin treatment followed by targeted treatment: a longitudinal study.
    Lancet. 2018;391:1599-1607.
    PubMed     Text format     Abstract available


  103. BARNETT R
    Syphilis.
    Lancet. 2018;391:1471.
    PubMed     Text format    


    March 2018
  104. PARK KB, Khan U, Seung K
    Open letter to The Global Fund about its decision to end DPRK grants.
    Lancet. 2018;391:1257.
    PubMed     Text format    


  105. SHARMA D
    Commitments to an end to tuberculosis renewed in India.
    Lancet. 2018;391:1138.
    PubMed     Text format    


  106. GOOSBY E, Jamison D, Swaminathan S, Reid M, et al
    The Lancet Commission on tuberculosis: building a tuberculosis-free world.
    Lancet. 2018;391:1132-1133.
    PubMed     Text format    


  107. WINGFIELD T, Tovar MA, Datta S, Saunders MJ, et al
    Addressing social determinants to end tuberculosis.
    Lancet. 2018;391:1129-1132.
    PubMed     Text format    


  108. DAVIES R
    Leo Martinez: striving to end childhood tuberculosis.
    Lancet. 2018 Mar 21. pii: S0140-6736(18)30680.
    PubMed     Text format    


  109. MCCALL C
    Rheumatic heart disease in the Pacific island nations.
    Lancet. 2018;391:926.
    PubMed     Text format    


    February 2018
  110. BURKI T
    End of a cholera epidemic in South Sudan declared.
    Lancet. 2018;391:647.
    PubMed     Text format    


  111. MUHSEN K, Green MS, Soskolne V, Neumark Y, et al
    Inequalities in non-communicable diseases in Israel - Authors' reply.
    Lancet. 2018;391:537.
    PubMed     Text format    


  112. WATTS N, Amann M, Ayeb-Karlsson S, Belesova K, et al
    The Lancet Countdown on health and climate change: from 25 years of inaction to a global transformation for public health.
    Lancet. 2018;391:581-630.
    PubMed     Text format    


  113. SMAJS D, Pospisilova P
    Macrolide resistance in yaws.
    Lancet. 2018 Feb 7. pii: S0140-6736(18)30205.
    PubMed     Text format    


  114. HONIGSBAUM M
    Superbugs and us.
    Lancet. 2018;391:420.
    PubMed     Text format    


    January 2018
  115. ZAROCOSTAS J
    Mega-crisis in DR Congo.
    Lancet. 2018;391:297-298.
    PubMed     Text format    


  116. THE LANCET
    A new vaccine for typhoid control.
    Lancet. 2018;391:96.
    PubMed     Text format    


  117. THE LANCET
    Tuberculosis: criteria for global leadership?
    Lancet. 2018;391:2.
    PubMed     Text format    


    December 2017
  118. HOLLAND TL, Fowler VG Jr
    Rifampicin for Staphylococcus aureus bacteraemia: give it ARREST.
    Lancet. 2017 Dec 14. pii: S0140-6736(17)33294.
    PubMed     Text format    


  119. THWAITES GE, Scarborough M, Szubert A, Nsutebu E, et al
    Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.
    Lancet. 2017 Dec 14. pii: S0140-6736(17)32456.
    PubMed     Text format     Abstract available


    September 2017
  120. POKROVSKY V
    Tuberculosis and HIV/AIDS: the alien and the predator.
    Lancet. 2017;390:1618-1619.
    PubMed     Text format    


    July 2017
  121. YACOUB M, Mayosi B, ElGuindy A, Carpentier A, et al
    Eliminating acute rheumatic fever and rheumatic heart disease.
    Lancet. 2017;390:212-213.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: